Found 627 with Last Name = 'colman' and Initial = 'pm' TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.00100nM ΔG°: <-68.5kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.00500nM ΔG°: -64.5kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.00500nM ΔG°: -64.5kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.00900nM ΔG°: -63.0kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
Affinity DataKi: <0.0100nMAssay Description:Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: <0.0100nMAssay Description:Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: <0.0100nMAssay Description:Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: <0.0100nMAssay Description:Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:Inhibition of BCL-XL (unknown origin) incubated for 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0100nM ΔG°: -62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: <0.0100nM ΔG°: <-62.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0120nM ΔG°: -62.3kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0120nM ΔG°: -62.3kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0130nM ΔG°: -62.1kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0140nM ΔG°: -62.0kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0140nM ΔG°: -62.0kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0150nM ΔG°: -61.8kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0160nM ΔG°: -61.6kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0160nM ΔG°: -61.6kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0170nM ΔG°: -61.5kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research
US Patent
Affinity DataKi: 0.0170nM ΔG°: -61.5kJ/moleT: 2°CAssay Description:Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr...More data for this Ligand-Target Pair
